Armstrong Fleming & Moore’s Bristol-Myers Squibb BMY Stock Holding History

Armstrong Fleming & Moore’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$547K	Hold	9,015	–	–	0.23%	61
2025 Q4	$486K	Buy	9,015 +983	+12%	+$47.3K	0.22%	62
2025 Q3	$362K	Sell	8,032 -32	-0.4%	-$1.49K	0.17%	73
2025 Q2	$373K	Buy	+8,064	New	+$396K	0.2%	68
2025 Q1	–	Sell	-8,149	Closed	-$461K	–	85
2024 Q4	$461K	Hold	8,149	–	–	0.28%	60
2024 Q3	$422K	Hold	8,149	–	–	0.25%	65
2024 Q2	$338K	Hold	8,149	–	–	0.22%	67
2024 Q1	$442K	Hold	8,149	–	–	0.31%	61
2023 Q4	$418K	Hold	8,149	–	–	0.32%	62
2023 Q3	$473K	Hold	8,149	–	–	0.46%	49
2023 Q2	$521K	Buy	+8,149	New	+$546K	0.48%	47

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Armstrong Fleming & Moore's BMY Position: Q1 2026 in Review

Armstrong Fleming & Moore held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 9,015 shares worth $547K. The position accounts for 0.23% of the portfolio, ranked #61.

Armstrong Fleming & Moore first reported a position in BMY in Q2 2023 and has held it in 11 quarters since. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Armstrong Fleming & Moore held 9,015 shares of Bristol-Myers Squibb worth $547K as of Q1 2026.
Armstrong Fleming & Moore left its Bristol-Myers Squibb share count unchanged in Q1 2026.
Bristol-Myers Squibb made up 0.23% of Armstrong Fleming & Moore's portfolio in Q1 2026, its #61 holding.
Armstrong Fleming & Moore first reported a position in Bristol-Myers Squibb in Q2 2023 and has held it in 11 quarters since.
2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Armstrong Fleming & Moore's 13F filing for Q1 2026, filed 13 Apr 2026.